Exam Preview for 35476: Grand Rounds: Tinnitus Evaluation & Managem

Grand Rounds: Tinnitus Evaluation & Management, in partnership with the University of Mississippi Medical Center

Please note: exam questions are subject to change.

1. The AAO-HNS has recommended the use of this label to describe tinnitus related to a specific cause other than sensorineural hearing loss: Primary tinnitus Secondary tinnitus Idiopathic tinnitus None of the above
2. In cases of secondary pulsatile tinnitus, a bilateral presentation is often related to: Arteriovenous malformation Glomus tumor Idiopathic intracranial hypertension None of the above
3. What percentage of patients with tinnitus report secondary pulsatile tinnitus? ~0% ~1% ~10% ~50%
4. What percentage of patients receiving cochlear implants report some tinnitus relief? 0% Less than 10% Greater than 75% None of the above
5. Which of the below are alternatives for tinnitus management of an ear without hearing? Cochlear implant CROS device Cognitive Behavioral Therapy All of the above
6. Which pathology can create a unilateral hearing loss with a conductive component and better than expected bone conduction thresholds, but normal middle ear immittance? Otitis media with complete effusion Semicircular canal dehiscence Ossicular discontinuity None of the above
7. The less common semicircular canal dehiscence of the posterior canal is often attributed to a: Head trauma Viral infection High jugular bulb Tumor
8. The best counseling approach for tinnitus management is: Tinnitus Retraining Therapy Tinnitus Activities Treatment Psychotherapy based (CBT, Mindfullness, etc) All of the above can work, depends on the patient
9. What medications are FDA approved for tinnitus treatment? SSRIs Cyclobenzaprine Benzodiazepine None of the above, not drug is FDA approved for tinnitus treatment
10. Which questionnaire helps to determine if hearing loss or tinnitus are the primary complaint? Tinnitus Functional Index Tinnitus Handicap Inventory Tinnitus and Hearing Survey None of the above